Answers are grounded in this paper and cite their sources.
Quantitative OCTA-based classification of type 1 MNV, performed at baseline, provided useful information in terms of the functional outcome achievable after 24 months of anti-VEGF treatment.
No takes yet. Share an insight, caveat, or question.
Arrigo et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: